The future of Public-Private-Partnerships for R&D in healthcare: will the COVID-19 experience change the game?”
The rapid development of a range of COVID-19 vaccines during the pandemic has renewed interest in public-private partnerships. For example, governments and international agencies have partnered with private pharmaceutical companies to fund research and development programmes. How did these partnerships develop? Did their development incorporate insights from previous initiatives for outbreak management? What have been the challenges thus far and how will this experience shape future public-private partnerships for R&D in healthcare? Join us in this webinar to find out whether COVID-19 has been a game-changer.
Barbara Kerstien, European Commission
Vasee Moorthy, World Health Organization, Geneva
Magda Chlebus, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Yannis Natsis, European Public Health Alliance
Dimitra Panteli & Erica Richardson (European Observatory on Health Systems and Policies)